Team Rubicon Announces the COVID-19 Emergency Food Assistance Program in Collaboration with Patient Advocate Foundation and Funded by the Bristol Myers Squibb Foundation GlobeNewswire
Janssen Announces Submission of Two Applications to US FDA Seeking Approval of SIMPONI ARIA® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis | Antibodies | News Channels PipelineReview.com